Nottingham Advisors, Inc. Amgen Inc Transaction History

Nottingham Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $182,969 - $209,392	920 New	920 $217,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $195,288 - $228,804	-920 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $204,157 - $237,912	920 New	920 $230,000
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $199,069 - $237,056	-920 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $37,842 - $48,640	-200 Reduced 17.86%	920 $221,000
Q2 2019 Feb 13, 2020	BUY	$166.7 - $195.41 $186,704 - $218,859	1,120 New	1,120 $248,000
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $186,704 - $218,859	-1,120 Closed	0 $0
Q2 2018 Jul 17, 2018	SELL	$166.05 - $186.51 $33,210 - $37,302	-200 Reduced 15.15%	1,120 $219,000
Q1 2018 Feb 13, 2020	BUY	$169.43 - $198.0 $223,647 - $261,360	1,320 New	1,320 $292,000
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $223,647 - $261,360	-1,320 Closed	0 $0
Q4 2017 Jan 29, 2018	SELL	$168.79 - $188.59 $69,372 - $77,510	-411 Reduced 23.74%	1,320 $230,000
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $289,578 - $330,621	1,731	1,731 $323,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Nottingham Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Nottingham Advisors, Inc. with notifications on news.